Evidence map›Paper›PMID 36877425›Full record

ArticleMagma (New York, N.Y.)2023

Optimization of cobalt ferrite magnetic nanoparticle as a theranostic agent: MRI and hyperthermia.

Zahra Mohammadi, Alireza Montazerabadi, Rasoul Irajirad, Neda Attaran, Hormoz Abedi, Seyed Ali Mousavi Shaegh, Ameneh Sazgarnia

Abstract read
PubMed Publisher
In one paragraph

Article in Magma (New York, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 12 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Zahra MohammadiRadiological Technology Department of Actually Paramedical Sciences, Babol University of Medical Sciences, Babol, Iran.ORCID http://orcid.org/0000-0001-7236-2535
Alireza MontazerabadiMedical Physics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Rasoul IrajiradFinetech in Medicine Research Center, Iran University of Medical Sciences, Tehran, Iran.
Neda AttaranDepartment of Medical Nanotechnology, Science and Search Branch, Islamic Azad University, Tehran, Iran.
Hormoz AbediMedical Physics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Seyed Ali Mousavi ShaeghOrthopedic Research Center, Mashhad University of Medical Sciences, P.O. Box 9187145785, Mashhad, Iran.
Ameneh SazgarniaMedical Physics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. sazgarniaa@mums.ac.ir.
Mashhad University of Medical Sciences · IRBabol University of Medical Sciences · IRIran University of Medical Sciences · IRIslamic Azad University, Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveMagnetic nanoparticles (MNPs) are considered a theranostic agent in MR imaging, playing an effective role in inducing magnetic hyperthermia. Since, high-performance magnetic theranostic agents are characterized by superparamagnetic behavior and high anisotropy, in this study, cobalt ferrite MNPs were optimized and investigated as a theranostic agent.

methodsCoFe

resultsFormation of CoFe

conclusionThe formation of multi-core MNPs by dextran coating is expected to improve the magnetic properties of the nanostructure, leading to optimization of theranostic parameters, so that CoFe

Indexed as

Hyperthermia, InducedMagnetite NanoparticlesCobaltDextransFerric CompoundsMagnetic Resonance ImagingPrecision MedicineCobaltcobalt ferriteDextransFerric CompoundsMagnetite NanoparticlesCobalt ferriteDextranMagnetic hyperthermiaMRITheranostic

Identifiers

PMID36877425
OpenAlexW4323294932

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.